These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2968808)

  • 1. Positron emission tomography imaging of dopamine and serotonin receptors in Huntington's chorea.
    Wong DF; Wagner HN; Links JM; Dannals RF; Folstein S; Ravert HT; Tune L; Pearlson G; Frost JJ; Folstein M
    Am J Physiol Imaging; 1988; 3(1):51. PubMed ID: 2968808
    [No Abstract]   [Full Text] [Related]  

  • 2. Atlas of dopamine receptor images (PET) of the human brain.
    Inoue Y; Wagner HN; Wong DF; Links JM; Frost JJ; Dannals RF; Rosenbaum AE; Takeda K; Di Chiro G; Kuhar MJ
    J Comput Assist Tomogr; 1985; 9(1):129-40. PubMed ID: 3155755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease: studies with structural imaging techniques and positron emission tomography.
    Mazziotta JC
    Semin Neurol; 1989 Dec; 9(4):360-9. PubMed ID: 2534934
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography studies of neurotransmitter systems.
    Sawle GV; Brooks DJ
    J Neurol; 1990 Dec; 237(8):451-6. PubMed ID: 1981574
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease.
    Hägglund J; Aquilonius SM; Bergström K; Eckernäs SA; Hartvig P; Lundqvist H; Långström B; Malmborg P; Någren K
    Adv Neurol; 1987; 45():99-101. PubMed ID: 2950732
    [No Abstract]   [Full Text] [Related]  

  • 7. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients].
    Botsch H; Oepen G; Deuschl G; Wolff G
    Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.
    Holthoff VA; Koeppe RA; Frey KA; Penney JB; Markel DS; Kuhl DE; Young AB
    Ann Neurol; 1993 Jul; 34(1):76-81. PubMed ID: 8390806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging neuroreceptors in the human brain in health and disease.
    Wagner HN; Dannals RF; Frost JJ; Wong DF; Ravert HT; Wilson AA; Links JM; Burns HD; Kuhar MJ; Snyder SH
    Radioisotopes; 1985 Feb; 34(2):103-7. PubMed ID: 2986204
    [No Abstract]   [Full Text] [Related]  

  • 10. Positron emission tomography and central neurotransmitter systems in movement disorders.
    Weeks RA; Brooks DJ
    Fundam Clin Pharmacol; 1994; 8(6):503-17. PubMed ID: 7721227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between CT scan changes and the duration of illness in Huntington's chorea (author's transl)].
    Konagaya M; Mukai E; Murakami N; Muroga T; Sobue I
    Rinsho Shinkeigaku; 1980 Feb; 20(2):113-20. PubMed ID: 6445252
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET.
    Andrews TC; Brooks DJ
    Mol Med Today; 1998 Dec; 4(12):532-9. PubMed ID: 9866823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography in the diagnosis of Huntington's disease.
    Lee CC; Chen ST; Lu CS; Hsi MS
    Changgeng Yi Xue Za Zhi; 1986 Sep; 9(3):157-64. PubMed ID: 2970288
    [No Abstract]   [Full Text] [Related]  

  • 14. New techniques for understanding Huntington's disease.
    Hurley RA; Jackson EF; Fisher RE; Taber KH
    J Neuropsychiatry Clin Neurosci; 1999; 11(2):173-5. PubMed ID: 10333989
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging strategies in depression.
    Grasby PM
    J Psychopharmacol; 1999 Dec; 13(4):346-51. PubMed ID: 10667610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imaging of D2 dopamine receptor].
    Hatazawa J; Itoh M; Ido T
    Nihon Rinsho; 1991 Jul; 49(7):1546-50. PubMed ID: 1832197
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autoradiography of neurotransmitter receptors in whole human brain hemisphere sections].
    Cselényi Z; Håkan H; Csiba L; Gulyás B
    Orv Hetil; 1999 Aug; 140(31):1737-42. PubMed ID: 10463033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography after fetal transplantation in Huntington's disease.
    Furtado S; Sossi V; Hauser RA; Samii A; Schulzer M; Murphy CB; Freeman TB; Stoessl AJ
    Ann Neurol; 2005 Aug; 58(2):331-7. PubMed ID: 16049929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Receptors in positron emission tomography].
    Suehiro M
    No To Shinkei; 1982 Sep; 34(9):853-62. PubMed ID: 6291562
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.